Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

May 1, 2019; Volume 60,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Van Dongen, Guus A.M.S.

    1. You have access
      Fully Automated 89Zr Labeling and Purification of Antibodies
      Alex J. Poot, Kevin W.A. Adamzek, Albert D. Windhorst, Maria J.W.D. Vosjan, Saskia Kropf, Hans-Jurgen Wester, Guus A.M.S. van Dongen and Danielle J. Vugts
      Journal of Nuclear Medicine May 1, 2019, 60 (5) 691-695; DOI: https://doi.org/10.2967/jnumed.118.217158
    2. You have access
      Brain Access of Monoclonal Antibodies as Imaged and Quantified by 89Zr-Antibody PET: Perspectives for Treatment of Brain Diseases
      Sophie E.M. Veldhuijzen van Zanten, Philip C. De Witt Hamer and Guus A.M.S. van Dongen
      Journal of Nuclear Medicine May 1, 2019, 60 (5) 615-616; DOI: https://doi.org/10.2967/jnumed.118.220939
  2. Van Laere, Koen

    1. You have access
      18F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446
      Michel Koole, Mark E. Schmidt, Anja Hijzen, Paulien Ravenstijn, Corinne Vandermeulen, Donatienne Van Weehaeghe, Kim Serdons, Sofie Celen, Guy Bormans, Marc Ceusters, Wei Zhang, Luc Van Nueten, Hartmuth Kolb, Jan de Hoon and Koen Van Laere
      Journal of Nuclear Medicine May 1, 2019, 60 (5) 683-690; DOI: https://doi.org/10.2967/jnumed.118.216747
  3. Van Nostrand, Douglas

    1. You have access
      Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients
      Athanasios Bikas, Di Wu, Evelyn Bethancourt, Michael Orquiza, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky and Douglas Van Nostrand
      Journal of Nuclear Medicine May 1, 2019, 60 (5) 638-643; DOI: https://doi.org/10.2967/jnumed.118.213256
  4. Van Nueten, Luc

    1. You have access
      18F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446
      Michel Koole, Mark E. Schmidt, Anja Hijzen, Paulien Ravenstijn, Corinne Vandermeulen, Donatienne Van Weehaeghe, Kim Serdons, Sofie Celen, Guy Bormans, Marc Ceusters, Wei Zhang, Luc Van Nueten, Hartmuth Kolb, Jan de Hoon and Koen Van Laere
      Journal of Nuclear Medicine May 1, 2019, 60 (5) 683-690; DOI: https://doi.org/10.2967/jnumed.118.216747
  5. Van Weehaeghe, Donatienne

    1. You have access
      18F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446
      Michel Koole, Mark E. Schmidt, Anja Hijzen, Paulien Ravenstijn, Corinne Vandermeulen, Donatienne Van Weehaeghe, Kim Serdons, Sofie Celen, Guy Bormans, Marc Ceusters, Wei Zhang, Luc Van Nueten, Hartmuth Kolb, Jan de Hoon and Koen Van Laere
      Journal of Nuclear Medicine May 1, 2019, 60 (5) 683-690; DOI: https://doi.org/10.2967/jnumed.118.216747
  6. Veldhuijzen Van Zanten, Sophie E.M.

    1. You have access
      Brain Access of Monoclonal Antibodies as Imaged and Quantified by 89Zr-Antibody PET: Perspectives for Treatment of Brain Diseases
      Sophie E.M. Veldhuijzen van Zanten, Philip C. De Witt Hamer and Guus A.M.S. van Dongen
      Journal of Nuclear Medicine May 1, 2019, 60 (5) 615-616; DOI: https://doi.org/10.2967/jnumed.118.220939
  7. Vosjan, Maria J.W.D.

    1. You have access
      Fully Automated 89Zr Labeling and Purification of Antibodies
      Alex J. Poot, Kevin W.A. Adamzek, Albert D. Windhorst, Maria J.W.D. Vosjan, Saskia Kropf, Hans-Jurgen Wester, Guus A.M.S. van Dongen and Danielle J. Vugts
      Journal of Nuclear Medicine May 1, 2019, 60 (5) 691-695; DOI: https://doi.org/10.2967/jnumed.118.217158
  8. Vugts, Danielle J.

    1. You have access
      Fully Automated 89Zr Labeling and Purification of Antibodies
      Alex J. Poot, Kevin W.A. Adamzek, Albert D. Windhorst, Maria J.W.D. Vosjan, Saskia Kropf, Hans-Jurgen Wester, Guus A.M.S. van Dongen and Danielle J. Vugts
      Journal of Nuclear Medicine May 1, 2019, 60 (5) 691-695; DOI: https://doi.org/10.2967/jnumed.118.217158
  9. Wadas, Thaddeus J.

    1. You have access
      89Zr-Chloride Can Be Used for Immuno-PET Radiochemistry Without Loss of Antigen Reactivity In Vivo
      Darpan N. Pandya, Nikunj B. Bhatt, Frankis Almaguel, Stephanie Rideout-Danner, Howard D. Gage, Kiran Kumar Solingapuram Sai and Thaddeus J. Wadas
      Journal of Nuclear Medicine May 1, 2019, 60 (5) 696-701; DOI: https://doi.org/10.2967/jnumed.118.216457
  10. Walczak, Piotr

    1. You have access
      A Distinct Advantage to Intraarterial Delivery of 89Zr-Bevacizumab in PET Imaging of Mice With and Without Osmotic Opening of the Blood–Brain Barrier
      Wojciech G. Lesniak, Chengyan Chu, Anna Jablonska, Yong Du, Martin G. Pomper, Piotr Walczak and Miroslaw Janowski
      Journal of Nuclear Medicine May 1, 2019, 60 (5) 617-622; DOI: https://doi.org/10.2967/jnumed.118.218792
« Previous (Pages : 13 14 15 16 17 18 19 ... 19) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 60 (5)
Journal of Nuclear Medicine
Vol. 60, Issue 5
May 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Deep Learning Analysis of Upright-Supine High-Efficiency SPECT Myocardial Perfusion Imaging for Prediction of Obstructive Coronary Artery Disease: A Multicenter Study
  • A Distinct Advantage to Intraarterial Delivery of 89Zr-Bevacizumab in PET Imaging of Mice With and Without Osmotic Opening of the Blood–Brain Barrier
  • Novel Structured Reporting Systems for Theranostic Radiotracers
  • Continuing Board Certification: Vision for the Future
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
  • Total-Body Perfusion Imaging with [11C]-Butanol
More...
SNMMI

© 2025 SNMMI

Powered by HighWire